KENNEY CHRISTOPHER JOHN

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 45% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 22%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
KENNEY CHRISTOPHER JOHN's trades of Xenon Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-13 2026-03-13
PlS Planned sale
28,415 -2.4%
161.96
US$3,246,599 		28,415 -2.4% 161.96 US$3,246,599
2026-03-13 2026-03-13
PrS Proposed sale
94,127
191.83
US$2,097,076 		94,127 191.83 US$2,097,076
2026-03-11 2026-03-10
PlS Planned sale
17,739 -29.1%
136.42
US$3,728,976 		17,739 -29.1% 136.42 US$3,728,976
2026-03-10 2026-03-10
PrS Proposed sale
2,771
60.11
US$166,559 		2,771 60.11 US$166,559
2023-03-24 2023-03-24
S Sale
700 -100.0%
35.01
US$24,507 		700 -100.0% 35.01 US$24,507
2022-01-21 2022-01-21
B Purchase
700 +inf%
28.81
US$20,167 		700 +inf% 28.81 US$20,167